High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Palantir stock has struggled for months, but the company may have just given investors some hope again. Shares of Palantir surged 29.45% on Aug. 4, the trading day after Palantir reported second-quarter results that topped Wall Street's expectations. The company posted adjusted earnings of 41 cents ...
Investing.com - U.S. stock index futures were broadly higher on Wednesday as investors drew cautious optimism from signs that negotiations to reopen the Strait of Hormuz could be gaining traction, although disappointing reactions to earnings from Advanced Micro Devices and privately held SpaceX tempered enthusiasm for technology shares.
US stock futures edged higher on Wednesday as investors reacted to renewed hopes of easing tensions in the Middle East, while corporate earnings from SpaceX (NASDAQ:SPCX), Advanced Micro Devices (NASDAQ:AMD) and Novo Nordisk (NYSE:NVO) drove significant pre-market trading. Although geopolitical developments supported overall market sentiment, investors also assessed company-specific news, particularly Elon Musk’s latest comments, which weighed on both SpaceX and AMD shares.
Asian equities climbed again Wednesday, tracking another record on Wall Street, as tech firms continued to enjoy a revival after a month-long rout, with confidence also boosted by the prospect of an imminent deal to reopen the Strait of Hormuz.Crude tumbled more than five percent Tuesday -- and are down more than 10 percent this week -- after US Treasury Secretary Scott Bessent said a deal could be reached imminently with Tehran on re-opening the Strait of Hormuz to shipping traffic.
President Donald Trump discussed efforts to de-escalate US-Iran tensions with Qatari Emir Tamim bin Hamad Al Thani.
Hard drive makers Sandisk and Western Digital are due to report earnings after the closing bell Wednesday.
CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.
The entertainment company is set to report fiscal third-quarter earnings ahead of Wednesday’s opening bell.
The Danish drugmaker continues to rely on the success of semaglutide, branded as Wegovy for weight loss and Ozempic for diabetes.
Lemonade's Q2 revenues surged 79% as premiums and loss ratio improved, but its rich valuation and softer estimates make the stock a hold.
Autodesk currently trades at $246.30 per share and has shown little upside over the past six months, posting a small loss of 2.6%. The stock also fell short of the S&P 500’s 7.1% gain during that period.
Paul Mueller's Q2 revenues jump 29% y/y, but lower margins weigh on earnings as strong pharmaceutical demand and a healthy backlog support the results.
Shares of one automation technology provider slipped after earnings, while another jumped. The new $13.15 midpoint implies fourth quarter earnings per share of about $3.60. Shares of automation technology provider Zebra Technologies were up 20% at $350 after it reported better-than-expected fiscal second-quarter numbers.
Investing.com -- Societe Generale told clients in a note on Tuesday that U.S. earnings strength is broadening beyond technology, and it expects the S&P 500 to reach 8,000, urging investors to "buy the momentum dip."
The number you need to know on Palantir right after earnings.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
